Modifications

A Sydney company promoting alternatives to conventional medical tests has admitted that its tests are not diagnostic tests and do not reveal any specific medical condition.<br><br>The consumer watchdog, the Australian Competition and Consumer Commission (ACCC), said on Thursday it and Australian Biologics Testing Services Pty Ltd had settled legal action taken by the ACCC in relation to claims made by Biologics in brochures and on its website in 2001 and 2002.<br><br>The ACCC alleged that the claims were false and misleading and unsupported by scientific testing.<br><br>The ACCC said Australian Biologics and its director, Janette Burke, had now given the Federal Court undertakings not to make 29 specific claims about the efficacy of its services.<br><br>"Australian Biologics and Ms Burke have agreed that these tests are not diagnostic tests and the results of such tests are not indicative of a specific medical condition", the ACCC said.<br><br>Australian Biologics provided services including [[Thermographie de régulation|thermography]], live blood analysis <ref>https://www.psiram.com/de/index.php/Lebendblutanalyse (analyse du sang vivant)</ref> and the Bolans clot retraction test.<br><br>Biologics had claimed the thermography tests, which measure skin temperature, could assess a patient's condition with regard to the strain the patient could bear before an operation or vaccination.<br><br>The company also claimed that the Bolans clot retraction test - an examination of a dried blood preparation - indicated a specific function of the heart or ovary or prostate or other human organ.<br><br>Biologics had also claimed that the live blood analysis test - an examination of a wet blood perapration - provided valuable information about a body's digestive and immune systems.

A Sydney company promoting alternatives to conventional medical tests has admitted that its tests are not diagnostic tests and do not reveal any specific medical condition.<br><br>The consumer watchdog, the Australian Competition and Consumer Commission (ACCC), said on Thursday it and Australian Biologics Testing Services Pty Ltd had settled legal action taken by the ACCC in relation to claims made by Biologics in brochures and on its website in 2001 and 2002.<br><br>The ACCC alleged that the claims were false and misleading and unsupported by scientific testing.<br><br>The ACCC said Australian Biologics and its director, Janette Burke, had now given the Federal Court undertakings not to make 29 specific claims about the efficacy of its services.<br><br>"Australian Biologics and Ms Burke have agreed that these tests are not diagnostic tests and the results of such tests are not indicative of a specific medical condition", the ACCC said.<br><br>Australian Biologics provided services including [[Thermographie de régulation|thermography]], live blood analysis <ref>https://www.psiram.com/de/index.php/Lebendblutanalyse (analyse du sang vivant)</ref> and the Bolans clot retraction test.<br><br>Biologics had claimed the thermography tests, which measure skin temperature, could assess a patient's condition with regard to the strain the patient could bear before an operation or vaccination.<br><br>The company also claimed that the Bolans clot retraction test - an examination of a dried blood preparation - indicated a specific function of the heart or ovary or prostate or other human organ.<br><br>Biologics had also claimed that the live blood analysis test - an examination of a wet blood perapration - provided valuable information about a body's digestive and immune systems.

== Accord transactionnel entre l'ACC et Australian Biologics ==

== Accord transactionnel entre l'ACCC et Australian Biologics ==

L'ACCC règle une poursuite contre Australian Biologics

L'ACCC règle une poursuite contre Australian Biologics

L'ACCC a allégué que l'Australian Biologics a enfreint l'article 52 de la Trade Practices Act 1974, qui interdit aux sociétés de se livrer à un comportement trompeur ou mensonger ; l'article 53(c), qui interdit aux sociétés de déclarer que des biens ou des services sont parrainés, approuvés, caractéristiques de rendement, accessoires, utilisations ou avantages dont elles ne disposent pas ; l'article 55A, qui interdit aux sociétés d'adopter un comportement pouvant tromper le public sur la nature, les caractéristiques, la pertinence ou la quantité des services.<br>15 Juillet 2004<ref>https://www.findlaw.com.au/news/4604/accc-settles-proceedings-against-australian-biolog.aspx Article publié le 15 juillet 2004</ref>

L'ACCC a allégué que l'Australian Biologics a enfreint l'article 52 de la Trade Practices Act 1974, qui interdit aux sociétés de se livrer à un comportement trompeur ou mensonger ; l'article 53(c), qui interdit aux sociétés de déclarer que des biens ou des services sont parrainés, approuvés, caractéristiques de rendement, accessoires, utilisations ou avantages dont elles ne disposent pas ; l'article 55A, qui interdit aux sociétés d'adopter un comportement pouvant tromper le public sur la nature, les caractéristiques, la pertinence ou la quantité des services.<br>15 Juillet 2004<ref>https://www.findlaw.com.au/news/4604/accc-settles-proceedings-against-australian-biolog.aspx Article publié le 15 juillet 2004</ref>

== Article à propos du Bolan's Clot Retraction Test et du laboratoire Australian Biologics sur Quackwatch ==

== Article à propos du Bolan's Clot Retraction Test et du laboratoire Australian Biologics sur Quackwatch ==